IRWD IRONWOOD PHARMACEUTICALS INC.

Ownership history in Sarissa Capital Management LP  ·  33 quarters on record

AI Ownership Summary

Sarissa Capital Management LP reported IRONWOOD PHARMACEUTICALS INC. (IRWD) in 33 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 28.9% in 2023 Q4. The latest visible filing shows IRWD at 24.07% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this IRWD ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Sarissa Capital Management LP's position in IRONWOOD PHARMACEUTICALS INC., and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

IRWD was reported at 24.07% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
28.9% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Sarissa Capital Management LP held IRWD — position size vs. price
% of Fund (quarterly)    IRWD price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 15,919,435 0% 24.07% $53.6M 2026-02-14 (Est.) $4.50
2025 Q3 UNCHANGED 15,919,435 0% 11.56% $20.9M 2025-11-14 $3.14
2025 Q2 REDUCED 15,919,435 -470,565 -2.9% 7.40% $11.4M 2025-08-14 $1.07
2025 Q1 UNCHANGED 16,390,000 0% 15.57% $24.1M 2025-05-15 $0.59
2024 Q4 UNCHANGED 16,390,000 0% 22.49% $72.6M 2025-02-14 $1.92
2024 Q3 UNCHANGED 16,390,000 0% 16.78% $67.5M 2024-11-14 $4.11
2024 Q2 UNCHANGED 16,390,000 0% 18.04% $106.9M 2024-08-14 $4.34
2024 Q1 UNCHANGED 16,390,000 0% 24.97% $142.8M 2024-05-15 $6.56
2023 Q4 UNCHANGED 16,390,000 0% 28.90% $187.5M 2024-02-14 $15.45
24 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Sarissa Capital Management LP and IRWD

These are the practical questions this page is built to answer before you even open the full history table.

How long has Sarissa Capital Management LP reported owning IRWD?

Sarissa Capital Management LP reported IRWD across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported IRWD position in Sarissa Capital Management LP's portfolio?

The largest reported portfolio weight for IRWD was 28.90% in 2023 Q4.

What is the latest reported IRWD position on this page?

The most recent filing on this page is 2025 Q4, when Sarissa Capital Management LP reported 15,919,435 shares, equal to 24.07% of portfolio, with an estimated market value of $53.6M.

What does the chart on this IRWD ownership page compare?

The chart compares Sarissa Capital Management LP's quarterly IRWD portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Sarissa Capital Management LP Holdings